Table 1.
| Zone of Clearance (mm) | Interpretation | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibiotic | PM185 | PM187 | PR1 | J53 | J53:pPM187 | J53:pPR1 | ||||||
| Ampicillin | 24 | S | 6 | R | 14 | R | 21 | S | 17 | S | 17 | S |
| Cefazolin | 9 | R | 9 | R | 6 | R | 25 | S | 8 | R | 9 | R |
| Cefotetan | 11 | R | 14 | I | 6 | R | 33 | S | 11 | R | 10 | R |
| Ceftriaxone | 17 | R | 17 | R | 18 | R | 35 | S | 15 | R | 14 | R |
| Ceftazidime | 23 | S | 20 | I | 22 | S | 30 | S | 17 | R | 15 | R |
| Cefepime | 20 | I | 19 | I | 19 | SDD | 36 | S | 28 | S | 26 | S |
| Meropenem | 20 | I | 22 | S | 6 | R | 32 | S | 25 | S | 27 | S |
| Imipenem | 20 | I | 24 | S | 15 | R | 33 | S | 31 | S | 32 | S |
| Pipercillin-Tazobactam | 33 | S | 26 | S | 31 | S | 30 | S | 30 | S | 31 | S |
| Ampicillin-Sulbactam | 23 | S | 18 | S | 6 | R | 24 | S | 20 | S | 22 | S |
| Ciprofloxacin | 36 | S | 32 | S | 27 | S | 25 | S | 25 | S | 25 | S |
| Levoflocaxin | 35 | S | 30 | S | 26 | S | 25 | S | 25 | S | 25 | S |
| Gentamicin | 23 | S | 15 | S | 16 | S | 25 | S | 25 | S | 26 | S |
| Amikacin | 22 | S | 24 | S | 24 | S | 25 | S | 25 | S | 26 | S |
| Trimethoprim-sulfamethoxazole | 30 | S | 23 | S | 6 | R | 35 | S | 25 | S | 6 | R |
| Colistin | 6 | R | 6 | R | 6 | R | 16 | S | 24 | S | 16 | S |
| Aztreonam | 38 | S | 35 | S | 35 | S | 36 | S | 35 | S | 35 | S |
| Doxycyline | 6 | R | 6 | R | 6 | R | 22 | S | 22 | S | 22 | S |
| Minocycline | 11 | R | 10 | R | 6 | R | 26 | S | 26 | S | 26 | S |
| Tigecycline | 18 | I | 23 | S | 20 | S | 29 | S | 29 | S | 30 | S |
| Carbapenem Inactivation Method | Indeterminate | Positive | Positive | Negative | Positive | Positive | ||||||